| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC65883 | 3,5-Dichloro-6-iodopyrazolo[1,5-a]pyrimidine Featured |
|
|
| DC65884 | CCR2-RA Featured |
|
|
| DC65885 | Stilbamidine dihydrochloride Featured | Stilbamidine dihydrochloride is a blocker of neuromuscular transmission and axonal conduction. It is used to study the distribution of the drug in the organs and tissues of rats following intravenous injection. |
|
| DC65886 | MCU-i11 Featured | MCU-i11 is a novel negative modulator of the MCU, binding MICU1 and impairing muscle cell growth. |
|
| DC65888 | 2,4,6-Triisopropyl-m-phenylene diisocyanate Featured |
|
|
| DC65889 | 3-Oxa-1-azaspiro[4.5]decane-2,4-dione Featured |
|
|
| DC65890 | 5,5-Difluoro-5a-methyl-1H,4H,4aH,5H,5aH,6H-cyclopropa[f]indazole-3-carboxylic acid Featured |
|
|
| DC65891 | GI 181771 Featured | GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity. |
|
| DC65892 | Cyclopropyl-prop-2-ynyl-amine Featured |
|
|
| DC65893 | Pyrithione Featured | Pyrithione, a Transition metal complexe, is a zinc ionophore that causes increased zinc levels within mammalian cells. Pyrithione has potent bactericidal and anti-fungal activity. |
|
| DC65894 | 3-bromo-2-(2-hydroxyethyl)thiophene Featured |
|
|
| DC65895 | 5-Acetyl-2-bromobenzaldehyde Featured |
|
|
| DC65896 | PSB-15160 Featured |
|
|
| DC65897 | SLU-PP-1072 Featured | SLU-PP-1072 is a novel Selective ERRα/γ Inverse Agonist, Inhibiting the Warburg Effect and Inducing Apoptosis in Prostate Cancer Cells. |
|
| DC65898 | LMTK3 inibitor C28 Featured | LMTK3-IN-1 (compound C28) is an ATP-competitive inhibitor of lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM)，that acts by degrading LMTK3 via the ubiquitin-proteasome pathway. LMTK3-IN-1 shows anticancer activity in a variety of cancer cell lines and in vivo BC mouse models. LMTK3-IN-1 induces apoptosis in BC cell lines at 10-20 μM. |
|
| DC60559 | PT-179 Featured | PT-179 is a new orthogonal immunomodulatory drug (IMiD) derivative that binds CRBN but does not induce degradation of off-target proteins. PT-179 potently degrades proteins fused to SD40 at either the N or C terminus. |
|
| DC65899 | Des-iPr-TAS-116 Featured |
|
|
| DC65900 | 1-Piperidinecarboxylic acid, 4-bromo-3-oxo-, 1,1-dimethylethyl ester Featured |
|
|
| DC65901 | PSB-1901 Featured | PSB-1901 is a potent A2B adenosine receptor (A2BAR) antagonist with Kis of 0.0835 nM and 0.131 nM for human and mouse A2BARs respectively. PSB-1901 can be used for the research of cancer. |
|
| DC65902 | 2-Amino-8-oxononanoic acid HCl Featured | 2-Amino-8-oxononanoic acid HCl is a biochemical |
|
| DC65903 | (2Z)-2-Fluorobut-2-enedioic acid Featured | 2-Fluorofumarate is a bioactive chemical. |
|
| DC65904 | 1-Cyanocyclopropy Featured |
|
|
| DC65905 | CB75559092 Featured |
|
|
| DC65906 | 4-bromo-1-(phenylmethyl)- 3-Piperidinone Featured |
|
|
| DC65907 | Protonstatin-1 Featured | Protonstatin-1 is a selective small-molecule inhibitor of PM H+ -ATPase activity that inhibits auxin transport. |
|
| DC65908 | SBFI-26 Featured | SBFI-26 (SBFI26) is a small molecule inhibitor of epidermal- and brain-specific FABP5 and FABP7 that effectively increases anandamide signaling; dose-dependently reduces mechanical hyperalgesia in vivo, demonstrates significant analgesic and anti-inflammatory properties; also suppresses the malignant progression of castration resistant prostate cancer cells by competitively binding to oncogenic FABP5. |
|
| DC65909 | IM176OUT05 Featured | IM176OUT05 is a high solubility biguanide. IM176OUT05 activates stem cell metabolism, promotes hair regrowth and increases stemness induction and maintenance during the pluripotent stem cell generation process. IM176OUT0 inhibits mitochondrial electron transport chain (ETC) activity with an IC50 of 3.2 μM. |
|
| DC65910 | 3-Amino-4,5-dimethylthiophene-2-carboxylic acid Featured |
|
|
| DC65911 | WAY-639483 Featured |
|
|
| DC65912 | 5-HT2A receptor agonist-3 Featured | 5-HT2A receptor agonist-3 is the most selective agonist for the human 5-HT2A receptor yet discovered, with a Ki of 2.5 nM, and with 124-fold selectivity for 5-HT2A over the structurally similar 5-HT2C receptor. |
|
